David P. Schenkein
Director · Prime Medicine, Inc.
- 2024
- Jun 8, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David P. Schenkein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nancy Thornberry - $262K in DNLI purchases and sales in the last 12 months
- Alexander O. Schuth - $137K in DNLI purchases and sales in the last 12 months
- Peter Scott Chin - $37K in DNLI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David P. Schenkein?
David P. Schenkein is a corporate insider, tracked as Director of Prime Medicine, Inc. (PRME). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David P. Schenkein last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 4 filings going back to 2024.
Has David P. Schenkein been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.93M) across all tracked filings.
